Summary To search for the signalling pathways in lung cancer relevant to its aggressive behaviour, we studied tyrosine phosphorylated proteins in lung cancer cell lines and surgical specimens. We found that the profiles of protein phosphorylation were closely matched among these cell lines and cancer tissues of different histological origins, and 100 -130 kDa proteins were the major components of phosphorylated proteins. In surgical specimens, approximately half of the cases showed tyrosine phosphorylation of these proteins in a tumourspecific manner, and phosphorylation of these proteins showed good correlation with the survival length of patients after operation. By immunoprecipitation with specific antibodies, we found that pl25FAK, p120 and ,Bcatenin were the major components of tyrosine-phosphorylated proteins in the surgical specimens. These results suggest that tyrosine phosphorylation of these proteins may play a role in tumour relapse and is available as a clinical marker.
Despite the progress of modern combined therapy, prognosis of lung cancer is extremely miserable among all malignancies. To identify signalling pathways specific for tumour, tyrosine kinases that showed tumour-specific expression have been studied. Elevated expression of epidermal growth factor (EGF) receptors (Cerny et al., 1986; Veale et al., 1987; Dazzi et al., 1989; Berger et al., 1987; Haeder et al., 1988; Siegfried, 1987 ) and c-erbB-2 genes (Kern et al., 1990; Schneider et al., 1989; Weiner et al., 1990) in non-small-cell lung cancer have been reported. Autocrine growth by insulinlike growth factor I was observed in small-cell lung cancer cells (Macaulay et al., 1988 (Macaulay et al., , 1990 . However, tyrosine kinases examined in these studies were limited to a few members of receptor-type oncogenes, and signalling pathways in the cancer tissues critical for tumorigenesis remain to be identified.
To analyse the signalling through tyrosine phosphorylation in human cancer, we have studied phosphotyrosine (pTyr)-containing proteins in various cancer cell lines with anti-pTyr antibody (Hamaguchi et al., 1988; Takeshima et al., 1991) . To obtain more clues, we examined pTyrcontaining proteins in lung cancer tissues surgically resected from patients. In this report, we show that roughly half the cases of lung cancer tissues we examined have tyrosine phosphorylation of 100-130 kDa proteins and phosphorylation of these proteins, correlates with the survival time of the patients. In addition, we show tyrosine phosphorylation of p125FAK, p120 and XK-catenin in these surgical specimens.
These proteins were known as major components of the cell adhesion system and their tyrosine phosphorylation showed good correlation with transforming activity of v-Src kinase (Schaller et al., 1992; Illic et al., 1995; Matsuyoshi et al., 1992; Hamaguchi et al., 1988 Hamaguchi et al., , 1993a Illic et al., 1995; Reynolds et al., 1989 Reynolds et al., , 1992 . Thus, tyrosine phosphorylation of these proteins may perturb cell-cell adhesion and activate tumour cell movement, invasion and metastasis. Preparation of anti-phosphotyrosine antibody and immunoblotting An affinity-purified antibody that specially recognised pTyr residues was prepared as described previously (Hamaguchi et al., 1988) . To detect tyrosine phosphorylation of immunoprecipitated proteins, peroxidase (PO)-conjugated anti-pTyr antibody (Transduction Lab.) was used.
Cell lysates were prepared as described previously (Takeshima et al., 1991) . Frozen tissue samples were crushed into fine pieces, suspended in a buffer containing 2% sodium dodecyl sulphate (SDS) and 5% mercaptoethanol, and immediately homogenised. Lysates were boiled and stocked at -80°C until use.
Assay of protein concentration, SDS-7.5% polyacrylamide gel electrophoresis (PAGE) and immunoblotting with anti-pTyr antibody were described previously (Hamaguchi et al., 1988 (Hamaguchi et al., , 1993a .
Autoradiography was performed on an imaging plate for bio-image analyser (Fuji), or by ECL chemiluminescence system (Amersham).
Immunoprecipitation Immunoprecipitation was performed as described previously (Hamaguchi et al., 1993b We next examined the tyrosine phosphorylation of p125FAK in these cancer tissues. We could not examine all the cases because of the shortness of tumour lysates, but tyrosine phosphorylation of p125FAK was observed in two cancer tissues in a tumour-specific manner (Figure 4, Figure la , a subset of proteins of 100-130 kDa was tyrosine phosphorylated in lung cancer cell lines of different histological origins. Tyrosine phosphorylation of similar proteins was widely observed in other cell lines derived from oesophageal, gastric and colon cancer (Figure lb) . To assess the specificity of anti-pTyr antibody, we examined the inhibitory effect of the phosphoamino acids upon antibody-antigen recognition as previously described (Takeshima et al., 1991) . Addition of 5 mM pTyr to the antipTyr antibody solution completely blocked the detection of these proteins, indicating that these proteins were indeed tyrosine phosphorylated (data not shown).
Since the major tyrosine-phosphorylated proteins ranged from 100 -130 kDa, we examined the phosphorylation of p125FAK and p120. As shown in Figure 2 , both p125FAK and p120 were tyrosine phosphorylated and co-migrate with major tyrosine-phosphorylated proteins in these cell lines.
Tyrosine-phosphorylated proteins including pJ25FAK in human lung cancer tissues We next examined pTyr-containing proteins in surgical specimens. Of 44 lung cancer tissues examined, we found tumour-specific elevation of tyrosine phosphorylation in 20 cases (Figure 3a) , and the profiles of tyrosine-phosphorylated proteins in these cases were similar irrespective of the difference in histology. We found tyrosine phosphorylation of a subset of proteins of 100 -130 (a) and p120 (b) in human lung cancer cell lines, QG56 and QG90, were examined by immunoprecipitating (IP) with antip125FAK or anti-pl20 followed by immunoblotting (IB) with antipTyr antibody. W, whole cell lysate; ppt, immunoprecipitated fraction.
was detectable in samples immunoprecipitated without antip125FAK (Figure 4 , lanes A and B) but undetectable with POconjugated anti-pTyr antibody (Figure 5a and c), suggesting it to be a non-specific band detected by secondary antibody.
To confirm tyrosine phosphorylation of p125FAK, we immunoprecipitated p125FAK repeatedly from the same cancer tissue lysates and probed with anti-pTyr antibody together with whole cell lysate and supernatant ( Figure 5 ). PO-conjugated anti-pTyr antibody was used in the following experiments to avoid non-specific binding of secondary antibody. Tyrosine phosphorylation of pl25FAK, which comigrated with one of the two major pTyr-containing proteins was again clearly detected in tumour tissues of both cases and decreased by repeated immunoprecipitation (Figure 5a and c). Although repeated immunoprecipitation removed most of the tyrosine-phosphorylated pl25FAK from the lysate ( Figure  5a and b), the major pTyr-containing protein co-migrated with pl25FAK remained in the supernatant fraction, suggesting that there may be additional pTyr-containing proteins of similar molecular size to p125FAK
To characterise other pTyr-containing proteins in cancer tissues, we next immunoprecipitated p120, a-and fl-catenins, p130Cas or vinculin. These proteins are well-known tyrosine- precipitated with anti-p 120 antibody (Figure 5d and e), suggesting p120 as one of the major pTyr-containing proteins in cancer tissue. Tyrosine phosphorylation of a-and f,-catenins was examined. Expression of a-catenin was low and its tyrosine phosphorylation was undetectable (Figure 6a and b). ,B-catenin was clearly tyrosine phosphorylated and comigrated with a faint band below the two major pTyrcontaining proteins of cancer tissues (Figure 6c and d) . A pTyr-containing protein slightly larger than ,B-catenin was coimmunoprecipitated with f,-catenin ( Figure 6c ). We could not identify protein species of this band. In addiiton to the results with case 2, we found tyrosine phosphorylation of p120 and /3-catenin in another case (case 9). Tyrosine phosphorylation of vinculin and p130Cas was next examined. We could not detect phosphorylation of vinculin (Figure 7a and b) . Since anti-p 30Cas antibody was available only for immunoblotting, we immunoprecipitated pTyr-containing proteins from tissue lysate by anti-pTyr antibody and subsequently probed with anti-p 30Cas antibody together with whole cell lysate and We examined expression of EGF receptor and c-erbB-2 protein in these cancer tissues. All tumour tissues examined expressed EGF receptor to similar levels, but only two cases expressed c-erbB-2 in a tumour-specific manner and these cases were both adenocarcinoma with mediastinal node metastasis (data not shown). Tables I and II (Table I) . Tyrosine phosphorylation of these proteins was found in 47% (9 of 19 cases) of squamous cell carcinoma tissues and 43% (10 of 23 cases) of adenocarcinoma tissues. Tyrosine phosphorylation of these proteins was not associated with age (P = 0.54), sex (P = 0.29), the histological classification (P= 0.55), the tumour size (P=0.95), or pathological T factor of TNM classification (P=0.10) (Table I) . However, we found that the cases with nodal involvement (NI and N2) had clearly higher incidence of tyrosine phosphorylation of these proteins compared with those with no nodal involvement (NO) (P=0.01) ( Table I ). In addition, cases which showed tyrosine phosphorylation had a shorter survival length after operation compared with those without tyrosine phosphorylation (P=0.01). To extend these observations, we next examined the relationship between clinicopathological variables and disease-free survival time (Table II) phorylation of 100-130 kDa proteins was statistically significant (P = 0.03), although survival length showed poor correlation with nodal involvement (P = 0.16). The cumulative probability of disease-free survival is displayed in Figure  8 for p-stage of TNM and Figure 9 for 100-130 kDa proteins' phosphorylation. These results strongly suggested that the tyrosine phosphorylation of 100-130 kDa proteins, probably including pl25FAK, p120 and fJ-catenin, correlates with a malignant phenotype of lung cancer.
Association of 100-130 kDa proteins' phosphorylation with clinicopathological manifestations

Discussion
Evidence has been accumulated that oncogenes that encode tyrosine kinases are involved in tumorigenesis of human cancer. The results presented in this report demonstrate that, in lung cancer tissues, a subset of 100-130 kDa proteins was indeed tyrosine phosphorylated in a tumour-specific manner. Of 44 cases of lung cancer we examined, 20 cases showed tyrosine phosphorylation of these proteins. We found that the profiles of phosphorylation in cancer tissues resembled each other and similar phosphorylated proteins were also found in oesophageal and colorectal cancer tissues, despite the difference in histological types and origins of cancer. In addition, statistical analysis showed good correlation of these protein phosphorylations with poor prognosis of patients. These results suggest that signalling via tyrosine phosphorylation of these proteins may play an important role in tumorigenesis.
By histochemical analysis, amplification of EGF receptor (Cerny et al., 1986; Veale et al., 1987; Dazzi et al., 1989; Berger et al., 1987; Haeder et al., 1989; Siegfried, 1987) and c-erbB-2 (Kern et al., 1990; Schneider et al., 1989; Weiner et al., 1990) in human lung cancer tissues has been reported. However, we found no clear correlation between the levels of EGF receptor of c-erbB-2 expression and the levels of tyrosine phosphorylation in cancer tissues (data not shown). Moreover, neither tyrosine-phosphorylated proteins corre- By immunoprecipitation with specific antibodies, we found tyrosine phosphorylation of pl25F', p120 and -catenin in lung cancer tissues. Attention has been drawn to pl25F' by its unique structure and character (Schaller et al., 1992) . This kinase was found as a major pTyr-containing protein in RSV-transformed cells and appeared to localise to focal adhesions. Recent studies suggest that pl25FA' kinase is involved in multifanous cellular functions such as cell adhesion (Kornberg et al., 1992) , shape (Burridge et al., 1992) , motility and growth (Zachary et al., 1992) as well as transformation. Targeting of pl25F gene in mice resulted in a defect of mesoderm development, and cells from these embryos had reduced mobility in vitro (Illic et al., 1995) . pl25F' becomes tyrosine phosphorylated and activated in response to integrin-mediated binding of cells to the extracellular matrix, suggesting pl25FAK phosphorylation is important for cell adhesion and/or migration (Kornberg et al., 1992; Burridge et al., 1992) . f-catenin is one of the components of the cadherin-catenin cell adhesion system and appears to play a crucial role in cadherin-dependent cell adhesion. In the huiman gastric cancer cell line, HSC-39, mutation in the f-catenin gene that resulted in complete abolishment of E-cadherin-dependent cell-cell adhesion was observed, and transfection of the f-ctenin gene in the cells fully recovered the cell-cell adhesion (Kawanishi et al., 1995) . We have previously reported (Matsuyoshi et al., 1992; Hamaguchi et al., 1993a ) that cadherin dependent cell-cell adhesion was strongly erturbed upon tyrosine phosphorylation of f-catenin in RSV-transformed cells where cadherins and catenins were expressed and formed complexes as normal cells. Another pTyr-containing protein, pl20, was also identified as a major pTyr-containing protein in RSVtransformed cells whose phosphorylation closely correlated with cell transformation (Reynolds et al., 1989) . Later study showed that pl20 had close homology with a group of cell adhesion molecules, -catenin, plakoglobin and armadillo (Reynolds et al., 1992) , suggesting that p120 may also play a role in cell adhesion. Thus, tyrosine phosphorylation of these adhesion molcules may result in suppression of cell-cell adhesion and activated lung cancer cell migration, invasion and metastasis.
Besides p125FAK, 120 and f-catenin, other tyrosinephosphorylated proteins ranged 100-130 kDa were found in cancer tissue. At present, we do not know precisely how many and what kind of proteins are included. These tyrosinephosphorylated proteins included neither pl30cP, w-catenin nor vinculin. We found, however, that this subset of tyrosinephosphorylated proteins was found in various types of human cancer cell lines (Figure 1 ) and in the cancer tissues of other organs (Figure 3 ). Further characterisation of the species of the tyrosine-phosphorylated proteins is an important problem to be studied.
